drugset / Trial / NCT00330083

Safety of ALK Ragweed Tablet

NCT00330083 ↗

Phase 1 Completed 72 enrolled ALK-Abelló A/S
RandomizedSingle-groupDouble-blindTreatment

Summary

This trial is performed to assess whether ALK Ragweed Tablet is safe to use in adults

Timeline

Start
2006-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject ALK Ragweed Tablet Unknown — —

Indications